The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Moses Jennifer K. | Director | Grant(A) | 32K | — | $0 |
| Jul 1, 2026 | Kiselak Tomas | Director | Grant(A) | 32K | — | $0 |
| Jul 1, 2026 | Gheuens Sarah | Director | Grant(A) | 32K | — | $0 |
| Jul 1, 2026 | Morris Arlene | Director | Grant(A) | 32K | — | $0 |
| Jul 1, 2026 | Cain Christopher W. | Director | Grant(A) | 32K | — | $0 |
| Jul 1, 2026 | Ajer Jeffrey Robert | Director | Grant(A) | 32K | — | $0 |
| May 11, 2026 | Fairmount Funds Management LLC | Director, 10% Owner | Buy(P) | 1.2M | $17.00 | $20.0M |
| Mar 3, 2026 | Mahoney Stephen F. | President and CEO, Director | Tax withholding(F) | 7K | $30.19 | $224K |
| Mar 3, 2026 | Tousignant Jennifer | Chief Legal Officer | Tax withholding(F) | 2K | $30.19 | $51K |
| Mar 3, 2026 | Beetham Thomas W. | Chief Operating Officer | Tax withholding(F) | 3K | $30.19 | $92K |
| Mar 3, 2026 | Harmon Seth | Chief Financial Officer | Tax withholding(F) | 2K | $30.19 | $61K |
| Mar 2, 2026 | Tripuraneni Radhika | Chief Medical Officer | Grant(A) | 96K | — | $0 |
| Mar 2, 2026 | Tripuraneni Radhika | Chief Medical Officer | Grant(A) | 19K | — | $0 |
| Dec 31, 2025 | Tousignant Jennifer | Chief Legal Officer | Sell(S) | 2K | $31.16 | $71K |
| Oct 23, 2025 | Fairmount Healthcare Fund II GP LLC | Director, 10% Owner | Buy(P) | 455K | $22.00 | $10.0M |
| Jul 1, 2025 | Moses Jennifer K. | Director | Grant(A) | 21K | — | $0 |
| Jul 1, 2025 | Gheuens Sarah | Director | Grant(A) | 21K | — | $0 |
| Jul 1, 2025 | Ajer Jeffrey Robert | Director | Grant(A) | 21K | — | $0 |
| Jul 1, 2025 | Morris Arlene | Director | Grant(A) | 21K | — | $0 |
| Jul 1, 2025 | Kiselak Tomas | Director | Grant(A) | 21K | — | $0 |
| Jul 1, 2025 | Cain Christopher W. | Director | Grant(A) | 21K | — | $0 |
| Jun 10, 2025 | Fairmount Funds Management LLC | Director, 10% Owner | Option exercise(M) | 13K | $12.31 | $154K |
| Jun 10, 2025 | Fairmount Funds Management LLC | Director, 10% Owner | Option exercise(M) | 13K | — | $0 |
| Jun 9, 2025 | Fairmount Funds Management LLC | Director, 10% Owner | Option exercise(M) | 2K | $7.80 | $12K |
| Jun 9, 2025 | Fairmount Funds Management LLC | Director, 10% Owner | Option exercise(M) | 2K | — | $0 |
| Apr 7, 2025 | Ajer Jeffrey Robert | Director | Grant(A) | 42K | — | $0 |
| Mar 10, 2025 | Cain Christopher W. | Director | Grant(A) | 42K | — | $0 |
| Mar 10, 2025 | Tripuraneni Radhika | Chief Medical Officer | Grant(A) | 311K | — | $0 |
| Mar 3, 2025 | Harmon Seth | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Mar 3, 2025 | Harmon Seth | Chief Financial Officer | Grant(A) | 25K | — | $0 |
| Mar 3, 2025 | Beetham Thomas W. | Chief Operating Officer | Grant(A) | 226K | — | $0 |
| Mar 3, 2025 | Beetham Thomas W. | Chief Operating Officer | Grant(A) | 38K | — | $0 |
| Mar 3, 2025 | Mahoney Stephen F. | President and CEO, Director | Grant(A) | 73K | — | $0 |
| Mar 3, 2025 | Mahoney Stephen F. | President and CEO, Director | Grant(A) | 441K | — | $0 |
| Mar 3, 2025 | Tousignant Jennifer | Chief Legal Officer | Grant(A) | 21K | — | $0 |
| Mar 3, 2025 | Tousignant Jennifer | Chief Legal Officer | Grant(A) | 124K | — | $0 |
| Sep 27, 2024 | Mahoney Stephen F. | President and CEO, Director | Buy(P) | 21K | $23.33 | $499K |
| Sep 27, 2024 | Beetham Thomas W. | Chief Operating Officer | Buy(P) | 5K | $23.41 | $117K |
| Sep 13, 2024 | Fairmount Healthcare Fund II L.P. | Director, 10% Owner | Buy(P) | 1.6M | $18.75 | $30.0M |
| Jun 26, 2024 | Moses Jennifer K. | Director | Grant(A) | 21K | — | $0 |
| Jun 26, 2024 | Morris Arlene | Director | Grant(A) | 21K | — | $0 |
| Jun 26, 2024 | Kiselak Tomas | Director | Grant(A) | 21K | — | $0 |
| Jun 26, 2024 | Harwin Peter Evan | Director | Grant(A) | 21K | — | $0 |
| Jun 26, 2024 | Gheuens Sarah | Director | Grant(A) | 21K | — | $0 |
| Mar 28, 2024 | Fairmount Healthcare Fund II L.P. | Director, 10% Owner | Other(J) | 6K | — | — |
| Mar 28, 2024 | Fairmount Healthcare Fund II L.P. | Director, 10% Owner | Other(J) | 6K | — | — |
| Mar 28, 2024 | Fairmount Healthcare Fund II L.P. | Director, 10% Owner | Other(J) | 22K | — | $0 |
| Mar 28, 2024 | Fairmount Healthcare Fund II L.P. | Director, 10% Owner | Other(J) | 22K | — | $0 |
| Feb 12, 2024 | Tousignant Jennifer | Chief Legal Officer | Grant(A) | 290K | — | $0 |
| Feb 5, 2024 | Ciulla Thomas | Chief Medical Officer | Grant(A) | 50K | — | $0 |
| Jan 22, 2024 | Fairmount Healthcare Fund II L.P. | Director, 10% Owner | Buy(P) | 476K | $21.00 | $10.0M |
| Nov 10, 2023 | Harmon Seth | See Remarks | Grant(A) | 270K | — | $0 |
| Oct 30, 2023 | Mahoney Stephen F. | President and CEO, Director | Grant(A) | 1.3M | — | $0 |
| Oct 30, 2023 | Beetham Thomas W. | Chief Operating Officer | Grant(A) | 474K | — | $0 |
| Oct 30, 2023 | Fairmount Healthcare Fund GP LLC | Director | Grant(A) | 48K | $825.37 | $40.0M |
| Sep 21, 2023 | Gheuens Sarah | Director | Grant(A) | 40K | — | $0 |
| Jun 16, 2023 | Meisner Lara | Chief Legal Officer | Sell(S) | 27 | $28.35 | $765 |
| Jun 16, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 27 | $23.03 | $622 |
| Jun 16, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 28 | — | $0 |
| Jun 15, 2023 | Meisner Lara | Chief Legal Officer | Sell(S) | 2K | $28.02 | $64K |
| Jun 15, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 2K | $23.03 | $52K |
| Jun 15, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 2K | — | $0 |
| Jun 14, 2023 | Morris Arlene | Director | Grant(A) | 20K | — | $0 |
| Jun 14, 2023 | Kiselak Tomas | Director | Grant(A) | 20K | — | $0 |
| Jun 14, 2023 | Moses Jennifer K. | Director | Grant(A) | 20K | — | $0 |
| Jun 14, 2023 | Harwin Peter Evan | Director | Grant(A) | 20K | — | $0 |
| Jun 6, 2023 | Meisner Lara | Chief Legal Officer | Sell(S) | 5K | $25.02 | $128K |
| Jun 6, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 5K | $18.51 | $95K |
| Jun 6, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 5K | — | $0 |
| Jun 5, 2023 | Meisner Lara | Chief Legal Officer | Sell(S) | 499 | $25.03 | $12K |
| Jun 5, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 499 | $18.51 | $9K |
| Jun 5, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 499 | — | $0 |
| Jun 2, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 2K | $14.00 | $26K |
| Jun 2, 2023 | Meisner Lara | Chief Legal Officer | Sell(S) | 2K | $24.21 | $45K |
| Jun 2, 2023 | Meisner Lara | Chief Legal Officer | Option exercise(M) | 2K | — | $0 |
| Apr 12, 2023 | Myers Scott Dunseth | Chief Executive Officer, Director | Buy(P) | 4K | $25.37 | $101K |
| Mar 13, 2023 | Myers Scott Dunseth | Chief Executive Officer, Director | Buy(P) | 6K | $29.15 | $160K |
| Mar 9, 2023 | Meisner Lara | General Counsel and Secretary | Sell(S) | 30K | $29.07 | $871K |
| Feb 8, 2023 | Meisner Lara | General Counsel and Secretary | Grant(A) | 108K | — | $0 |
| Feb 8, 2023 | Humer Kristian | CFO and CBO | Grant(A) | 108K | — | $0 |
| Feb 8, 2023 | Melvin Carrie | COO | Grant(A) | 54K | — | $0 |
| Feb 8, 2023 | Katz Barrett | Chief Medical Officer | Grant(A) | 108K | — | $0 |
| Feb 6, 2023 | Myers Scott Dunseth | Chief Executive Officer, Director | Grant(A) | 250K | — | $0 |
| Feb 6, 2023 | Myers Scott Dunseth | Chief Executive Officer, Director | Grant(A) | 1.0M | — | $0 |
| Feb 2, 2023 | Violin Jonathan | Chief Executive Officer, Director | Sell(S) | 50K | $36.80 | $1.8M |
| Feb 2, 2023 | Violin Jonathan | Chief Executive Officer, Director | Sell(S) | 50K | $36.80 | $1.8M |
| Feb 2, 2023 | Violin Jonathan | Chief Executive Officer, Director | Option exercise(M) | 50K | $0.15 | $8K |
| Feb 2, 2023 | Violin Jonathan | Chief Executive Officer, Director | Option exercise(M) | 50K | — | $0 |
| Jan 23, 2023 | Meisner Lara | General Counsel and Secretary | Option exercise(M) | 5K | $23.03 | $114K |
| Jan 23, 2023 | Meisner Lara | General Counsel and Secretary | Sell(S) | 7K | $35.66 | $244K |
| Jan 23, 2023 | Meisner Lara | General Counsel and Secretary | Option exercise(M) | 2K | $14.00 | $26K |
| Jan 23, 2023 | Meisner Lara | General Counsel and Secretary | Option exercise(M) | 2K | — | $0 |
| Jan 23, 2023 | Meisner Lara | General Counsel and Secretary | Option exercise(M) | 5K | — | $0 |
| Jan 17, 2023 | Katz Barrett | Chief Medical Officer | Option exercise(M) | 25K | $23.03 | $572K |
| Jan 17, 2023 | Katz Barrett | Chief Medical Officer | Sell(S) | 25K | $37.21 | $925K |
| Jan 17, 2023 | Katz Barrett | Chief Medical Officer | Option exercise(M) | 25K | — | $0 |
| Jan 13, 2023 | Katz Barrett | Chief Medical Officer | Option exercise(M) | 4K | $23.03 | $96K |
| Jan 13, 2023 | Katz Barrett | Chief Medical Officer | Sell(S) | 4K | $37.01 | $153K |
| Jan 13, 2023 | Katz Barrett | Chief Medical Officer | Option exercise(M) | 4K | — | $0 |
| Jan 10, 2023 | Katz Barrett | Chief Medical Officer | Option exercise(M) | 47K | $23.03 | $1.1M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).